James Kronauge
Vorstandsvorsitzender bei Hesperos, Inc.
Profil
James F.
Kronauge is the founder of Iseek Biopharma, Inc. founded in 2021, where he holds the title of President.
He is currently the Co-Chief Executive Officer at Hesperos, Inc. since 2022.
Dr. Kronauge's former positions include Vice President-Process Development Chemistry at Molecular Insight Pharmaceuticals, Inc. and Assistant Professor at Harvard Medical School.
Dr. Kronauge's education history includes an undergraduate degree from Kent State University (Ohio) and an undergraduate degree from the University of Cincinnati (Ohio), as well as a doctorate from the Massachusetts Institute of Technology.
Aktive Positionen von James Kronauge
| Unternehmen | Position | Beginn |
|---|---|---|
Hesperos, Inc.
 Hesperos, Inc. Pharmaceuticals: OtherHealth Technology Hesperos, Inc. manufactures drugs and medicines. It is a global contract research organization (CRO) providing compound safety and efficacy testing services using its human-on-a-chip platform the multi-organ micro physiological systems available today. The company was founded by Michael L. Shuler & James J. Hickman in 2015 and is headquartered in Orlando, FL. | Vorstandsvorsitzender | 01.04.2022 |
| Iseek Biopharma, Inc. | Gründer | 01.01.2021 |
Ehemalige bekannte Positionen von James Kronauge
| Unternehmen | Position | Ende |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von James Kronauge
| Massachusetts Institute of Technology | Doctorate Degree |
| Kent State University (Ohio) | Undergraduate Degree |
| University of Cincinnati (Ohio) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
Hesperos, Inc.
Hesperos, Inc. Pharmaceuticals: OtherHealth Technology Hesperos, Inc. manufactures drugs and medicines. It is a global contract research organization (CRO) providing compound safety and efficacy testing services using its human-on-a-chip platform the multi-organ micro physiological systems available today. The company was founded by Michael L. Shuler & James J. Hickman in 2015 and is headquartered in Orlando, FL. | Health Technology |
| Iseek Biopharma, Inc. |
